Published in Aliment Pharmacol Ther on March 31, 2008
Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey. Pharm Pract (Granada) (2012) 0.97
Current practice and perception of screening for medication adherence in inflammatory bowel disease. J Clin Gastroenterol (2011) 0.96
Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.94
Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol (2010) 0.92
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases. Adv Ther (2015) 0.87
Stem cells as potential therapeutic targets for inflammatory bowel disease. Front Biosci (Schol Ed) (2010) 0.87
Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies. Patient Prefer Adherence (2014) 0.86
Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management. Dig Dis Sci (2015) 0.83
Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis. Patient Prefer Adherence (2015) 0.81
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterol (2013) 0.81
Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease. Dig Dis Sci (2011) 0.81
Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis. Clin Exp Gastroenterol (2014) 0.79
Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents. Inflamm Bowel Dis (2010) 0.79
Adherence in ulcerative colitis: an overview. Patient Prefer Adherence (2017) 0.79
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence. Patient Relat Outcome Meas (2010) 0.77
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? World J Gastrointest Pharmacol Ther (2015) 0.77
Predictors of medication adherence in pediatric inflammatory bowel disease patients at the Stollery Children's Hospital. Can J Gastroenterol (2009) 0.77
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine. Drug Des Devel Ther (2011) 0.76
Understanding of chemoprophylaxis and concordance in inflammatory bowel disease. World J Gastroenterol (2010) 0.76
Acarbose: a new option in the treatment of ulcerative colitis by increasing hydrogen production. Afr J Tradit Complement Altern Med (2012) 0.75
Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons. Middle East J Dig Dis (2016) 0.75
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease. Clin Exp Gastroenterol (2009) 0.75
Current practice and clinicians' perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians. World J Gastrointest Pharmacol Ther (2017) 0.75
Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study. BMC Gastroenterol (2017) 0.75
Improving Maintenance Medication Adherence in Adult Inflammatory Bowel Disease Patients: A Pilot Study. Health Psychol Res (2014) 0.75
Advances in inflammatory bowel disease: are patients taking their medicines? Interview by Paul C. Adams. Can J Gastroenterol (2009) 0.75
Managing ulcerative colitis by increasing hydrogen production via oral administration of Acarbose. Afr J Tradit Complement Altern Med (2013) 0.75
College inflammatory bowel disease (C-IBD) day: a targeted approach to shared decision-making in college age students with IBD-a 2-year pilot project. Int J Colorectal Dis (2017) 0.75
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
Is the two week rule for cancer referrals working? BMJ (2001) 7.90
Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60
Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell (1998) 7.03
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
NF-kappaB and the immune response. Oncogene (2006) 5.62
The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell (1997) 4.99
NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia (2011) 4.63
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (1991) 4.27
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Isolation of a putative phospholipase C gene of Drosophila, norpA, and its role in phototransduction. Cell (1988) 4.05
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science (2000) 4.04
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell (1995) 3.95
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer (2012) 3.80
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature (1995) 3.59
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev (1992) 3.47
High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil (2004) 3.44
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest (2001) 3.04
Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Res (2001) 2.91
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut (2008) 2.77
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.74
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res (1999) 2.60
NF-kappa B and rel proteins in innate immunity. Adv Immunol (1995) 2.53
Self-reported preclinical disability identifies older women with early declines in performance and early disease. J Clin Epidemiol (2001) 2.45
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J Cell Biol (1996) 2.25
Intra-articular bupivacaine: potentially chondrotoxic? Br J Anaesth (2009) 2.20
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J (1992) 2.19
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev (1999) 2.17
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Reversible ischemia determined by xenon-enhanced CT after 90 minutes of complete basilar artery occlusion. AJNR Am J Neuroradiol (1999) 2.09
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Microsatellites for linkage analysis of genetic traits. Trends Genet (1992) 2.05
The risk of childbearing re-evaluated. Am J Public Health (1981) 2.03
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth (1994) 2.01
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol (1996) 2.01
Validation of self-reported hearing loss. The Blue Mountains Hearing Study. Int J Epidemiol (2001) 2.00
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
A case for a combined mother and child card. Indian Pediatr (1987) 1.92
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol Cell Biol (1996) 1.91
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol (1997) 1.88
Anaerobic acidogenesis of wastewater sludge. J Water Pollut Control Fed (1975) 1.87
Rescue of the Drosophila phototransduction mutation trp by germline transformation. Science (1985) 1.85
A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet (1994) 1.81
Reactive oxygen species level in follicular fluid--embryo quality marker in IVF? Hum Reprod (2006) 1.80
Additional microsatellite markers for mouse genome mapping. Mamm Genome (1991) 1.79
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2005) 1.72
Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem (2001) 1.71
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol (1998) 1.68
Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J Biol Chem (2001) 1.68
Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet (1989) 1.66
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Socio-cultural factors affecting breast feeding and other infant feeding practices in an urban community. Indian Pediatr (1976) 1.64
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem (2000) 1.57
Prevalence of diabetes and impaired fasting glucose in a selected population with special reference to influence of family history and anthropometric measurements--the Kolkata policeman study. J Assoc Physicians India (2008) 1.56
A second opsin gene expressed in the ultraviolet-sensitive R7 photoreceptor cells of Drosophila melanogaster. J Neurosci (1987) 1.56
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. Proc Natl Acad Sci U S A (1996) 1.54
Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry (2000) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry (1991) 1.53
Goiter prevalence and iodine nutritional status of school children in a sub-Himalayan Tarai region of eastern Uttar Pradesh. Indian Pediatr (2008) 1.52
A ferromagnet in a continuously tunable random field. Nature (2007) 1.52
Haplotyping in pedigrees via a genetic algorithm. Hum Hered (2000) 1.51
Current-induced polarization and the spin Hall effect at room temperature. Phys Rev Lett (2006) 1.50
Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians. Int J Obes (Lond) (2006) 1.49
cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium. J Cell Physiol (1994) 1.47
Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science (2000) 1.46
bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol (1987) 1.46
Reduced long-term survival following major peptic ulcer haemorrhage. Br J Surg (1997) 1.46
Cesarean section. Risk and benefits for mother and fetus. JAMA (1983) 1.45
Structure of salicylaldehyde thiosemicarbazone. Acta Crystallogr C (1988) 1.44
The Royal College of Radiologists Breast Group breast imaging classification. Clin Radiol (2009) 1.43
Keratitis, ichthyosis, deafness (KID) syndrome--the first report from India. Clin Exp Dermatol (1993) 1.43
The role of soda lime during administration of inhaled nitric oxide. Br J Anaesth (1994) 1.43
Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J Clin Virol (2006) 1.42
Hepatic dysfunction in childhood malaria. Arch Dis Child (1979) 1.42
Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr (2001) 1.41
Oral lesions of lichen planus. Int J Dermatol (1993) 1.41
Odor in pemphigus. Dermatology (1992) 1.40
Dietary and serum magnesium levels in patients with acute myocardial infarction, coronary artery disease and noncardiac diagnoses. J Am Coll Nutr (1994) 1.40
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol (1999) 1.40
Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res (2000) 1.39
Integrated child development services programme. Indian Pediatr (1989) 1.39